纽约医生Daniel Griffin至今年元旦，他治疗了一千多例病人。
本期要点：
In COVID-19 clinical update #47, Daniel Griffin reviews phase 3 results for Novavax and J&J vaccines, transmission in K-12 settings in Wisconsin, data on Lilly and Regeneron monoclonal antibody therapy, and a study of colchicine for treatment of disease.
Links for this episode
- Novavax vaccine phase 3 results (Novavax)
- J&J vaccine phase 3 results (J&J)
- COVID-19 and transmission in K-12 schools (MMWR)
- Lilly mAb therapy (NEJM)
- Regeneron mAb prophylaxis (Regeneron)
- Colchicine for COVID-19 (Cardiol Today)
